teserpaturev

  • July 28, 2021  

    Oncolytic Virus Teserpaturev Approved in Japan for Malignant Glioma Bookmark

    George Lundberg, MD

    Oncolytic viruses may offer serious hope as a very new type of treatment for malignant glioma. As reported by OncLive, the oncolytic virus teserpaturev was recently approved in Japan after a phase 2 clinical trial.

    .

    .